Silvia Taylor
Public Communications Contact bei NOVAVAX, INC.
Aktive Positionen von Silvia Taylor
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NOVAVAX, INC. | Public Communications Contact | - | - |
Investor Relations Kontakt | 17.06.2020 | - | |
Maryland Tech Council Venture Mentoring Services | Direktor/Vorstandsmitglied | 11.07.2023 | - |
Karriereverlauf von Silvia Taylor
Ehemalige bekannte Positionen von Silvia Taylor
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Investor Relations Kontakt | 28.06.2012 | 01.03.2018 |
Sucampo Pharma Americas LLC | Investor Relations Kontakt | - | 01.03.2018 |
PFIZER, INC. | Vertrieb & Marketing | 01.01.1999 | 01.01.2007 |
AUTOLUS THERAPEUTICS PLC | Public Communications Contact | - | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Vertrieb & Marketing | - | - |
Ausbildung von Silvia Taylor
University of Virginia | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 2 |
Operativ
Investor Relations Contact | 3 |
Sales & Marketing | 2 |
Public Communications Contact | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PFIZER, INC. | Health Technology |
NOVAVAX, INC. | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo Pharma Americas LLC | |
Maryland Tech Council Venture Mentoring Services |
- Börse
- Insiders
- Silvia Taylor
- Erfahrung